Cargando…

Targeted Therapy and Immunotherapy in Early-Stage Non-Small Cell Lung Cancer: Current Evidence and Ongoing Trials

The scenario of neoadjuvant and adjuvant settings in non-small cell lung cancer (NSCLC) is rapidly evolving. As already happened for the advanced disease, also early stages have entered the era of precision medicine, with molecular analysis and Programmed death-ligand 1 (PD-L1) evaluation that by no...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Scordilli, Marco, Michelotti, Anna, Bertoli, Elisa, De Carlo, Elisa, Del Conte, Alessandro, Bearz, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266864/ https://www.ncbi.nlm.nih.gov/pubmed/35806230 http://dx.doi.org/10.3390/ijms23137222

Ejemplares similares

NSCLC as the Paradigm of Precision Medicine at Its Finest: The Rise of New Druggable Molecular Targets for Advanced Disease
por: Michelotti, Anna, et al.
Publicado: (2022)

Therapeutical Options in ROS1—Rearranged Advanced Non Small Cell Lung Cancer
por: Stanzione, Brigida, et al.
Publicado: (2023)

Brain Metastases Management in Oncogene-Addicted Non-Small Cell Lung Cancer in the Targeted Therapies Era
por: De Carlo, Elisa, et al.
Publicado: (2022)

Acquired Resistance to Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer: How Do We Overcome It?
por: Bertoli, Elisa, et al.
Publicado: (2022)

Bone Metastasis and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC): Microenvironment and Possible Clinical Implications
por: Del Conte, Alessandro, et al.
Publicado: (2022)

Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical Implications
por: Bertoli, Elisa, et al.
Publicado: (2023)

The Change in Paradigm for NSCLC Patients with EML4–ALK Translocation
por: Bearz, Alessandra, et al.
Publicado: (2022)

Concurrent chemoradiotherapy with tomotherapy in locally advanced non-small cell lung cancer: a phase i, docetaxel dose-escalation study, with hypofractionated radiation regimen
por: Bearz, Alessandra, et al.
Publicado: (2013)

Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives
por: Lazzari, Chiara, et al.
Publicado: (2023)

Stereotactic radiotherapy for early stage non-small cell lung cancer: current standards and ongoing research
por: Vlaskou Badra, Eugenia, et al.
Publicado: (2021)

NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome
por: Michelotti, Anna, et al.
Publicado: (2021)

Bioresorbable Scaffolds: Current Evidence and Ongoing Clinical Trials
por: Bourantas, Christos V., et al.
Publicado: (2012)

Immunotherapy for Peritoneal Metastases from Gastric Cancer: Rationale, Current Practice and Ongoing Trials
por: Ruiz Hispán, Eva, et al.
Publicado: (2021)

Combination of Immunotherapy and Radiation Therapy in Gastrointestinal Cancers: An Appraisal of the Current Literature and Ongoing Research
por: Kumar, Ritesh, et al.
Publicado: (2023)

Neuroblastoma: an ongoing cold front for cancer immunotherapy
por: Kennedy, Paul T, et al.
Publicado: (2023)

Controversies in preoperative therapy in esophageal cancer: Current evidence and ongoing research
por: Ashok, Apurva, et al.
Publicado: (2019)

Outcomes of ALK positive lung cancer patients treated with crizotinib or second-generation ALK inhibitor: a monoinstitutional experience
por: De Carlo, Elisa, et al.
Publicado: (2018)

Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer
por: Russo, Francesca, et al.
Publicado: (2008)

Immunotherapy Moves to the Early-Stage Setting in Non-Small Cell Lung Cancer: Emerging Evidence and the Role of Biomarkers
por: Mielgo-Rubio, Xabier, et al.
Publicado: (2020)

Neoadjuvant immunotherapy for patients with non-small cell lung cancer—current evidence
por: Cao, Christopher, et al.
Publicado: (2020)

Immunotherapy for extensive-stage small-cell lung cancer: current landscape and future perspectives
por: Zhang, Shuang, et al.
Publicado: (2023)

Development of Immunotherapy Strategies Targeting Tumor Microenvironment Is Fiercely Ongoing
por: Bai, Rilan, et al.
Publicado: (2022)

Immunotherapy for HER2-Positive Breast Cancer: Clinical Evidence and Future Perspectives
por: Agostinetto, Elisa, et al.
Publicado: (2022)

Severe refractory asthma: current treatment options and ongoing research
por: Menzella, Francesco, et al.
Publicado: (2018)

Immunotherapy for Chordoma and Chondrosarcoma: Current Evidence
por: Traylor, Jeffrey I., et al.
Publicado: (2021)

Epilepsy Surgery: Current Status and Ongoing Challenges
por: KAWAI, Kensuke
Publicado: (2015)

The biosimilars journey: current status and ongoing challenges
por: Kos, Igor Age, et al.
Publicado: (2018)

Erratum: Development of immunotherapy strategies targeting tumor microenvironment is fiercely ongoing
Publicado: (2022)

Immunotherapy as a treatment to confront the ongoing opioid epidemic- A review
por: Dafny, Nachum
Publicado: (2022)

Immunotherapy for Colorectal Cancer with High Microsatellite Instability: The Ongoing Search for Biomarkers
por: Ros, Javier, et al.
Publicado: (2023)

Integration of immunotherapy into treatment of cervical cancer: Recent data and ongoing trials
por: Monk, Bradley J., et al.
Publicado: (2022)

Therapeutic decision based on molecular detection of resistance mechanism in an ALK-rearranged lung cancer patient: a case report
por: De Carlo, Elisa, et al.
Publicado: (2018)

Find the Flame: Predictive Biomarkers for Immunotherapy in Melanoma
por: Garutti, Mattia, et al.
Publicado: (2021)

Toward Understanding the Etiology of Male Breast Cancer: An Ongoing Research Challenge
por: Zeinomar, Nur, et al.
Publicado: (2021)

Digital Contact Tracing Against COVID-19 in Europe: Current Features and Ongoing Developments
por: Blasimme, Alessandro, et al.
Publicado: (2021)

Pharmacological Treatment for Social Cognition: Current Evidence
por: Riccardi, Cecilia, et al.
Publicado: (2021)

Neonatal Resuscitation with an Intact Cord: Current and Ongoing Trials
por: Katheria, Anup C.
Publicado: (2019)

Fluorosis: an ongoing challenge for India
por: Del Bello, Lou
Publicado: (2020)

Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small Cell Lung Cancer
por: Shukla, Nikhil, et al.
Publicado: (2021)

Immunotherapy in the Treatment of Metastatic Melanoma: Current Knowledge and Future Directions
por: Ralli, Massimo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jhti72v0nn97gn2g93cehkatak